Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Medecine Sciences : M/S|December 21, 2013
[Role of the p53 tumor suppressor in metabolism]Matthieu Lacroix, Laetitia Karine Linares, Laurent Le Cam
Frontiers in Oncology|May 2, 2022
Computational Model of Heterogeneity in Melanoma: Designing Therapies and Predicting OutcomesArran Hodgkinson, Dumitru Trucu, Matthieu Lacroix, et al.
The Journal of Investigative Dermatology|August 13, 2010
Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse modelAnaïs Briot, Matthieu Lacroix, Aurélie Robin, et al.
Molecular and Cellular Biology|July 1, 2004
The E4F protein is required for mitotic progression during embryonic cell cyclesLaurent Le Cam, Matthieu Lacroix, Maria A Ciemerych, et al.
Molecular Metabolism|November 6, 2019
Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancerMatthieu Lacroix, Romain Riscal, Giuseppe Arena, et al.
EMBO Reports|April 12, 2008
The histone-binding protein COPR5 is required for nuclear functions of the protein arginine methyltransferase PRMT5Matthieu Lacroix, Selma El Messaoudi, Geneviève Rodier, et al.
Nucleic Acids Research|March 21, 2020
SingleCellSignalR: inference of intercellular networks from single-cell transcriptomicsSimon Cabello-Aguilar, Mélissa Alame, Fabien Kon-Sun-Tack, et al.
Cancers|January 7, 2021
The p53 Pathway and Metabolism: The Tree That Hides the ForestAirelle Lahalle, Matthieu Lacroix, Carlo De Blasio, et al.
The Journal of Experimental Medicine|May 6, 2009
Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndromeAnaïs Briot, Céline Deraison, Matthieu Lacroix, et al.
Oncogene|January 16, 2003
IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cellsAriane Freund, Corine Chauveau, Jean-Paul Brouillet, et al.
Pageof 3